Global Peritoneal Dialysis Market

Global Peritoneal Dialysis Market size was valued at USD 9.25 billion in 2023 and is poised to grow from USD 10 billion in 2024 to USD 18.47 billion by 2032, growing at a CAGR of 8% during the forecast period (2025-2032)

The peritoneal dialysis (PD) market is experiencing significant growth, driven by its advantages over traditional hemodialysis, such as increased flexibility and reduced need for medical assistance. This home-based treatment is particularly beneficial for patients with some renal function, allowing for continuous self-monitoring and minimal dietary restrictions. Despite challenges related to patient accessibility and technological familiarity, the uptick in home dialysis usage has been notable, rising from 14.8% to 20% for patients with end-stage kidney disease (ESKD) under two years and from 11.7% to 13.7% for those between two to four years. The COVID-19 pandemic accelerated demand for dialysis supplies, and ongoing advancements in medical technology and growing support for home treatments will further enhance market opportunities moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peritoneal Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peritoneal Dialysis Market Segments Analysis

Global Peritoneal Dialysis Market is segmented by offering, modality, disease indication, end user and region. Based on offering, the market is segmented into peritoneal dialysis products and peritoneal dialysis services. Based on modality, the market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). Based on disease indication, the market is segmented into end-stage renal disease, acute kidney injury and other diseases. Based on end user, the market is segmented into home care settings, hospitals & independent dialysis centers and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Peritoneal Dialysis Market

The global peritoneal dialysis market is expected to experience significant growth during the projected period, driven by several key factors. The increasing prevalence of end-stage renal disease (ESRD), coupled with advancements in peritoneal dialysis technology, particularly in cyclers, is anticipated to boost market demand. Additionally, the rising preference for home dialysis treatment reflects a shift towards more patient-centered care. Peritoneal dialysis offers various advantages, such as lower costs compared to hemodialysis, a needle-free approach, enhanced mobility, user-friendly treatment processes, and fewer dietary limitations, all of which contribute to the market's international expansion.

Restraints in the Global Peritoneal Dialysis Market

The global peritoneal dialysis market faces several significant challenges that hinder its growth. Among the primary obstacles are the heightened risk of infections and treatment failures associated with the procedure, as well as complications arising from the need for permanent catheter insertion through the skin. Additionally, the complex regulatory processes required for the approval of new dialysis devices further impede innovation and market expansion. These factors contribute to the overall limitations faced by the market, making it more difficult for healthcare providers and patients to fully utilize the benefits of peritoneal dialysis as a treatment option.

Market Trends of the Global Peritoneal Dialysis Market

The global peritoneal dialysis market is poised for substantial growth, driven by several key factors including the rising incidence of End-Stage Renal Disease (ESRD), alongside the growing prevalence of diabetes and hypertension. Increased public awareness about peritoneal dialysis options, coupled with proactive governmental initiatives aimed at improving access to renal care, further stimulate market expansion. Furthermore, there is a shift towards adopting advanced technological treatment solutions, enhancing patient outcomes. Notably, developing nations, particularly China and India, are carving out significant market opportunities as they embrace peritoneal dialysis, illustrating a robust upward trend in global demand for this essential renal therapy.


1. Introduction
1.1. Objectives of the Study
1.2. Scope of the Report
1.3. Definitions
2. Research Methodology
2.1. Information Procurement
2.2. Secondary & Primary Data Methods
2.3. Market Size Estimation
2.4. Market Assumptions & Limitations
3. Executive Summary
3.1. Global Market Outlook
3.2. Supply & Demand Trend Analysis
3.3. Segmental Opportunity Analysis
4. Market Dynamics & Outlook
4.1. Market Overview
4.2. Market Size
4.3. Market Dynamics
4.3.1. Drivers & Opportunities
4.3.2. Restraints & Challenges
4.4. Porters Analysis
4.4.1. Competitive rivalry
4.4.2. Threat of substitute
4.4.3. Bargaining power of buyers
4.4.4. Threat of new entrants
4.4.5. Bargaining power of suppliers
5. Key Market Insights
5.1. Key Success Factors
5.2. Degree of Competition
5.3. Top Investment Pockets
5.4. Market Ecosystem
5.5. Market Attractiveness Index, 2024
5.6. PESTEL Analysis
5.7. Macro-Economic Indicators
5.8. Value Chain Analysis
5.9. Pricing Analysis
5.10. Technology Analysis
5.11. Trade Analysis
5.12. Regulatory Analysis
5.13. Patent Analysis
5.14. Case Study Analysis
6. Global Peritoneal Dialysis Market Size by Offering & CAGR (2025-2032)
6.1. Market Overview
6.2. Peritoneal Dialysis Products
6.2.1. Peritoneal Dialysis Solution Bags
6.2.2. Peritoneal Dialysis Machines
6.2.3. Peritoneal Dialysis Catheters
6.2.4. Peritoneal Dialysis Transfer Sets
6.2.5. Other Peritoneal Dialysis Products
6.3. Peritoneal Dialysis Services
7. Global Peritoneal Dialysis Market Size by Modality & CAGR (2025-2032)
7.1. Market Overview
7.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
7.3. Automated Peritoneal Dialysis (APD)
8. Global Peritoneal Dialysis Market Size by Disease Indication & CAGR (2025-2032)
8.1. Market Overview
8.2. End-Stage Renal Disease
8.3. Acute Kidney Injury
8.4. Other Diseases
9. Global Peritoneal Dialysis Market Size by End User & CAGR (2025-2032)
9.1. Market Overview
9.2. Home Care Settings
9.3. Hospitals & Independent Dialysis Centers
9.4. Other End Users
10. Global Peritoneal Dialysis Market Size & CAGR (2025-2032)
10.1. North America (Offering, Modality, Disease Indication, End User)
10.1.1. USA
10.1.2. Canada
10.2. Europe (Offering, Modality, Disease Indication, End User)
10.2.1. Germany
10.2.2. Spain
10.2.3. France
10.2.4. UK
10.2.5. Italy
10.2.6. Rest of Europe
10.3. Asia Pacific (Offering, Modality, Disease Indication, End User)
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Rest of Asia-Pacific
10.4. Latin America (Offering, Modality, Disease Indication, End User)
10.4.1. Brazil
10.4.2. Rest of Latin America
10.5. Middle East & Africa (Offering, Modality, Disease Indication, End User)
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Intelligence
11.1. Top 5 Player Comparison
11.2. Market Positioning of Key Players, 2024
11.3. Strategies Adopted by Key Market Players
11.4. Recent Developments in the Market
11.5. Company Market Share Analysis, 2024
11.6. Company Profiles of All Key Players
11.6.1. Company Details
11.6.2. Product Portfolio Analysis
11.6.3. Company's Segmental Share Analysis
11.6.4. Revenue Y-O-Y Comparison (2021-2023)
12. Key Company Profiles
12.1. Fresenius Medical Care AG (Germany)
12.1.1. Company Overview
12.1.2. Business Segment Overview
12.1.3. Financial Updates
12.1.4. Key Developments
12.2. Baxter International Inc. (US)
12.2.1. Company Overview
12.2.2. Business Segment Overview
12.2.3. Financial Updates
12.2.4. Key Developments
12.3. Medtronic PLC (Ireland)
12.3.1. Company Overview
12.3.2. Business Segment Overview
12.3.3. Financial Updates
12.3.4. Key Developments
12.4. DaVita Inc. (US)
12.4.1. Company Overview
12.4.2. Business Segment Overview
12.4.3. Financial Updates
12.4.4. Key Developments
12.5. Becton, Dickinson and Company (US)
12.5.1. Company Overview
12.5.2. Business Segment Overview
12.5.3. Financial Updates
12.5.4. Key Developments
12.6. Terumo Corporation (Japan)
12.6.1. Company Overview
12.6.2. Business Segment Overview
12.6.3. Financial Updates
12.6.4. Key Developments
12.7. Utah Medical Products, Inc. (US)
12.7.1. Company Overview
12.7.2. Business Segment Overview
12.7.3. Financial Updates
12.7.4. Key Developments
12.8. Diaverum AB (Sweden)
12.8.1. Company Overview
12.8.2. Business Segment Overview
12.8.3. Financial Updates
12.8.4. Key Developments
12.9. Medionics (US)
12.9.1. Company Overview
12.9.2. Business Segment Overview
12.9.3. Financial Updates
12.9.4. Key Developments
12.10. Newsol Technologies Inc. (US)
12.10.1. Company Overview
12.10.2. Business Segment Overview
12.10.3. Financial Updates
12.10.4. Key Developments
12.11. Apollo Dialysis Pvt. Ltd. (India)
12.11.1. Company Overview
12.11.2. Business Segment Overview
12.11.3. Financial Updates
12.11.4. Key Developments
12.12. U.S. Renal Care, Inc. (US)
12.12.1. Company Overview
12.12.2. Business Segment Overview
12.12.3. Financial Updates
12.12.4. Key Developments
12.13. Northwest Kidney Centers (US)
12.13.1. Company Overview
12.13.2. Business Segment Overview
12.13.3. Financial Updates
12.13.4. Key Developments
12.14. Relavo (US)
12.14.1. Company Overview
12.14.2. Business Segment Overview
12.14.3. Financial Updates
12.14.4. Key Developments
12.15. Mitra Industries Pvt. Ltd. (India)
12.15.1. Company Overview
12.15.2. Business Segment Overview
12.15.3. Financial Updates
12.15.4. Key Developments
12.16. JMS Co., Ltd. (Japan)
12.16.1. Company Overview
12.16.2. Business Segment Overview
12.16.3. Financial Updates
12.16.4. Key Developments
12.17. Amecath (China)
12.17.1. Company Overview
12.17.2. Business Segment Overview
12.17.3. Financial Updates
12.17.4. Key Developments
12.18. Polymedicure (India)
12.18.1. Company Overview
12.18.2. Business Segment Overview
12.18.3. Financial Updates
12.18.4. Key Developments
12.19. Huaren Pharmaceutical (China)
12.19.1. Company Overview
12.19.2. Business Segment Overview
12.19.3. Financial Updates
12.19.4. Key Developments
12.20. Awak Technologies (Singapore)
12.20.1. Company Overview
12.20.2. Business Segment Overview
12.20.3. Financial Updates
12.20.4. Key Developments
13. Conclusion & Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings